United Therapeutics
UTHR
UTHR
320 hedge funds and large institutions have $3.63B invested in United Therapeutics in 2019 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 103 increasing their positions, 94 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
10% more repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 94
5% more call options, than puts
Call options by funds: $23.6M | Put options by funds: $22.5M
0.38% less ownership
Funds ownership: 94.33% → 93.94% (-0.38%)
Holders
320
Holding in Top 10
7
Calls
$23.6M
Puts
$22.5M
Top Buyers
| 1 | +$44M | |
| 2 | +$29.3M | |
| 3 | +$20.1M | |
| 4 |
BlackRock
New York
|
+$19.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.8M |
Top Sellers
| 1 | -$51.1M | |
| 2 | -$49.5M | |
| 3 | -$31.9M | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$21.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$20.1M |